Evidence map›Paper›PMID 33520357›Full record

ReviewAmerican journal of cancer research2021

Macropinocytosis: mechanism and targeted therapy in cancers.

Feng Xiao, Jingying Li, Kai Huang, Xin Li, Yaping Xiong, Miaojing Wu, Lei Wu, Wei Kuang, Shigang Lv, Lei Wu and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in American journal of cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. EGF-Induced Macropinocytosis Promotes NAV1-Dependent Internalization of Occludin in Keratinocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Cellular Regulation of Macropinocytosis.International journal of molecular sciences · 2024
    Review
  16. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Feng XiaoDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Jingying LiDepartment of Comprehensive Intensive Care Unit, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Kai HuangDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Xin LiDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Yaping XiongDepartment of Anesthesiology, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Miaojing WuDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Lei WuDepartment of Emergency, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Wei KuangDepartment of Emergency, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Shigang LvDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Lei WuDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Xingen ZhuDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Hua GuoDepartment of Neurosurgery, The Second Affiliated Hospital of Nanchang University Nanchang 330006, Jiangxi, China.
Nanchang Institute of Technology · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macropinocytosis is a form of endocytosis which provides an effective way for non-selective uptakes of extracellular proteins, liquids, and particles. The endocytic process is initiated by the activation of the growth factors signaling pathways. After activation of the biochemical signal, the cell starts internalizing extracellular solutes and nutrients into the irregular endocytic vesicles, known as macropinosomes that deliver them into the lysosomes for degradation. Macropinocytosis plays an important role in the nutritional supply of cancer cells. Due to the rapid expansion of cancer cells and the abnormal vascular microenvironment, cancer cells are usually deprived of oxygen and nutrients. Therefore, they must transform their metabolism to survive and grow in this harsh microenvironment. To satisfy their energy needs, cancer cells enhance the activity of macropinocytosis. Therefore, this metabolic adaptation that is used by cancer cells can be exploited to develop new targeted cancer therapies. In this review, we discuss the molecular mechanism that actuates the process of macropinocytosis in a variety of cancers, and the novel anti-cancer therapeutics in targeting macropinocytosis.

Indexed as

cancer mechanismgrowth factorsMacropinocytosistargeted cancer therapy

Identifiers

PMID33520357
PMCPMC7840718
OpenAlexW3127966436

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.